Spring has nearly sprung, and round two of the Inflation Reduction Act's (IRA's) negotiation period has begun. | All of the ...

or about 14% of Medicare Part D’s prescription drug costs, according to CMS. The negotiated prices for the drugs will take effect in 2027. The second round of negotiations builds on the success ...

The Trump administration signaled Medicare drug price negotiations under the Inflation ... not total [Medicare parts B and D] spending,” Holz-Eakin told Health Care News. Under the IRA, CMS has the ...

Key Takeaways - - CMS is expected to issue the 2026 final rate notice for Medicare Advantage (MA) and Part D plans by April 7 ...

Opens in a new tab or window Medicare was authorized to negotiate prices it will pay for Part D drugs. Enbrel ... Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

The Inflation Reduction Act was passed in 2021 to reduce the government deficit, incentivize domestic energy production, and ...

Under the legislation, the Secretary of Health and Human Services will be able to negotiate the prices of selected drugs with a “high budget impact” provided via Medicare Parts B and D ...

The Senate Finance committee voted along party lines Tuesday to recommend Oz to the full Senate. That vote is expected soon.

March 14 (Reuters) - All drug manufacturers, including Novo Nordisk (NOVOb.CO), opens new tab and Teva Pharmaceuticals (TEVA.TA), opens new tab, whose medicines are part of the second round of ...

Former heart surgeon and television host Dr. Mehmet Oz testified Friday before the Senate Finance Committee over his nomination to head the Centers for Medicare and Medicaid Services under ...